Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The 2026 Guide Aetna's GLP-1 landscape shifted significantly in 2025 Zepbound is now non-formulary on most plans
GLP-1 medications, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound), were originally developed for type 2 diabetes and later approved for chronic weight management at full therapeutic doses
However, persistent tachycardia, chest pain, or fainting always warrant medical evaluation
With both injectable and oral medication options, our telehealth model and insurance handling, transitioning to a healthier lifestyle is made seamless
The contents of the vial are mixed gently with the diluent (avoiding shaking, which can denature the peptide) until fully dissolved
US$ 26.84
US$ 25.43
US$ 25.82
